#Interventional Oncology Device Market | Explore Tumblr posts and blogs

insightfulblogz · 17 hours ago

Text

Medical X-ray Market Opportunities, Statistics, COVID-19 Impact, and Forecast by 2032

Medical X-ray technology remains a fundamental diagnostic tool, offering critical insights into the internal structures of the body. Used for detecting fractures, identifying tumors, diagnosing respiratory diseases, and guiding certain medical procedures, X-ray imaging is indispensable in modern medicine. With technological advancements, medical X-ray devices now offer higher resolution, reduced radiation exposure, and enhanced imaging capabilities, enabling accurate and timely diagnoses that are vital for effective patient care.

The Medical X-ray Market was estimated at USD 14.25 billion in 2023 and is poised to reach 24.50 billion in 2032 which is anticipated to expand at a compound annual growth rate of 6.22% for the forecast period of 2024-2032.

Future Scope

The future of medical X-ray technology is expected to be driven by advancements in digital imaging, artificial intelligence, and portable X-ray systems. AI-driven image analysis has the potential to enhance diagnostic accuracy by identifying abnormalities that may be missed by human interpretation. Furthermore, the development of portable and handheld X-ray devices could bring imaging technology to underserved and remote areas, expanding access to quality healthcare. Innovations in 3D X-ray imaging and photon-counting detectors also promise to improve image quality while minimizing radiation doses.

Emerging Trends

Emerging trends in medical X-ray technology include the shift from analog to digital X-ray systems, which provide faster results and improved image clarity. AI integration is also transforming diagnostics, with AI algorithms analyzing X-ray images to detect early signs of disease. Another trend is the growth of mobile X-ray units, allowing for bedside imaging in emergency rooms, intensive care units, and other settings where patient mobility is limited. Additionally, low-dose radiation techniques are increasingly prioritized to enhance patient safety.

Applications

Medical X-rays are used in various healthcare settings for diagnostics, including orthopedics, oncology, pulmonology, and emergency medicine. They aid in the diagnosis of bone fractures, dental issues, lung diseases, and tumors. X-ray technology is also essential in guiding surgical procedures and is used in interventional radiology for precise treatment delivery. Its wide application across specialties makes it an invaluable tool in modern healthcare.

Key Points

Medical X-rays are essential for diagnosing fractures, tumors, and respiratory diseases.

Advances in digital imaging and AI are enhancing diagnostic precision and efficiency.

Portable X-ray devices are increasing accessibility in emergency and remote care settings.

3D imaging and low-dose radiation techniques are prioritized for improved safety and quality.

Conclusion

Medical X-ray technology continues to be a cornerstone of diagnostic imaging, empowering healthcare providers with detailed views of internal anatomy essential for accurate diagnoses. With ongoing advancements in digital imaging, AI integration, and low-radiation solutions, X-ray technology is set to further improve diagnostic precision, accessibility, and patient safety. As X-ray innovations evolve, they will continue to support healthcare systems worldwide, contributing to faster, more effective treatment and improving patient outcomes across various medical fields.

Read More Details: https://www.snsinsider.com/reports/medical-x-ray-market-3019

Akash Anand — Head of Business Development & Strategy

Email: [email protected]

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND)

#Medical X-ray Market #Medical X-ray Market Size #Medical X-ray Market Share #Medical X-ray Market Growth #Medical X-ray Market Trends

0 notes

health-views-updates · 12 days ago

Text

Digital Therapeutics Market Insight 2024 Size, Share, Growth Drivers, Future Scope, And Forecast To 2032

The Digital Therapeutics Market is experiencing unprecedented growth, driven by advancements in healthcare technology and increasing acceptance of digital health solutions across the globe. According to a recent report from SNS Insider, the Digital Therapeutics Market Revenue is set to reach remarkable heights as both healthcare providers and patients recognize the effectiveness and potential of digital therapeutics in managing chronic diseases, improving patient outcomes, and optimizing healthcare delivery.

The digital therapeutics sector is reshaping traditional healthcare paradigms by offering evidence-based, technology-driven solutions for disease prevention, management, and treatment. These solutions, including mobile health applications, wearable devices, and virtual care platforms, are designed to deliver interventions that can be as effective as conventional treatments but with greater accessibility and ease. This paradigm shift is being fueled by an increased emphasis on preventive healthcare and patient-centered models, where digital therapeutics play a central role in meeting diverse healthcare needs.

Growing partnerships between technology companies, healthcare providers, and pharmaceutical firms are further propelling the digital therapeutics market. With major industry players investing in research and development, the market is expected to see the emergence of more sophisticated, personalized, and regulated solutions tailored to specific health conditions, ranging from diabetes and cardiovascular diseases to mental health and respiratory disorders. The regulatory support and favorable policies from health authorities worldwide are also contributing to the rapid adoption of these therapeutic solutions, creating substantial opportunities for growth.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/3306

Digital therapeutics (DTx) are increasingly becoming mainstream, with clinical trials and real-world data supporting their effectiveness and adherence levels among patients. Unlike conventional pharmaceuticals, digital therapeutics can be customized in real-time to provide adaptive, user-specific interventions, making them particularly valuable in chronic disease management and mental health care. A broad spectrum of stakeholders in the healthcare industry, from payers to providers, is recognizing the role of digital therapeutics as part of an integrated care approach, further encouraging market expansion and patient engagement.

Additionally, digital therapeutics hold the potential to reduce healthcare costs by addressing inefficiencies in traditional care delivery. Studies show that DTx can decrease the frequency of hospital visits, shorten treatment cycles, and increase patient adherence, all of which contribute to lowering the overall burden on healthcare systems. This, in turn, appeals to governments and healthcare organizations seeking sustainable solutions to address the rising incidence of chronic diseases and mental health issues worldwide.

Key Market Drivers and Future Growth Prospects

The report from SNS Insider identifies several factors contributing to the robust growth of the digital therapeutics market. These include advancements in artificial intelligence (AI), machine learning, and data analytics, which enable digital therapeutics providers to enhance personalization and continuously improve patient engagement. Furthermore, the increasing availability of high-speed internet and mobile devices has expanded access to DTx solutions, making it easier for patients to receive care remotely, regardless of geographical barriers.

A strong pipeline of emerging DTx products is expected in the coming years, with companies focusing on expanding therapeutic areas, such as substance use disorders, oncology, and musculoskeletal conditions. As more applications are developed, tested, and approved, healthcare providers and patients will have an even wider range of options to integrate into their care plans, reinforcing the market’s potential for sustainable growth.

The report also highlights the role of investors in fueling this sector, with venture capitalists and strategic investors showing a growing interest in digital health and therapeutics startups. This influx of capital is helping companies scale, innovate, and navigate regulatory challenges more effectively, positioning digital therapeutics as a viable, long-term component of modern healthcare.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us: Akash Anand – Head of Business Development & Strategy [email protected] Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

0 notes

businessindustry · 17 days ago

Text

Pediatric Clinical Trial Market Forecast, Size 2024 to 2032

The Reports and Insights, a leading market research company, has recently releases report titled “Pediatric Clinical Trial Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global��Pediatric Clinical Trial Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Pediatric Clinical Trial Market?

The global pediatric clinical trial market was valued at US$ 16.5 Billion in 2023 and is expected to register a CAGR of 6.6% over the forecast period and reach US$ 29.3 Billion in 2032.

What are Pediatric Clinical Trial?

A pediatric clinical trial is a research study aimed at assessing the safety, efficacy, and appropriate dosing of medical interventions—such as medications, vaccines, or medical devices—in children and adolescents. These trials are critical for understanding how treatments affect younger populations, as children can react differently than adults due to their unique physiological, developmental, and metabolic traits. Conducted under strict ethical guidelines to protect child participants, these trials typically require parental consent and child assent. Pediatric clinical trials are essential for creating age-appropriate therapies that address the specific health needs of children.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2481

What are the growth prospects and trends in the Pediatric Clinical Trial industry?

The pediatric clinical trial market growth is driven by various factors and trends. The pediatric clinical trial market is experiencing growth, driven by a heightened emphasis on developing age-specific therapies and an increasing prevalence of pediatric diseases. Pharmaceutical companies and research organizations are recognizing the critical need to conduct clinical trials tailored specifically for children to ensure that medical treatments are both safe and effective for younger populations. Regulatory agencies are also stressing the importance of pediatric studies, resulting in greater investment in this field. Furthermore, advancements in technology and data analytics are enhancing trial design and patient recruitment, leading to more efficient studies. As the demand for customized pediatric healthcare continues to rise, the market for pediatric clinical trials is expected to expand significantly, facilitating the development of vital therapies for children. Hence, all these factors contribute to pediatric clinical trial market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Area

Oncology

Infectious Diseases

Cardiovascular Diseases

Metabolic Diseases

Respiratory Diseases

Diabetes

HIV

By Sponsor

Industry

Government Organizations

Non-Government Organizations

Associations

By Phases

Phase 1

Phase 2

Phase 3

Phase 4

North America

United States

Canada

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Poland

Benelux

Nordic

Rest of Europe

Asia Pacific

China<

Japan

India

South Korea

ASEAN

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Saudi Arabia

South Africa

United Arab Emirates

Israel

Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Synteract

ICON Plc.

Syneos Health

Medpace, Inc

PPD Inc.

Premier Research

LabCorp Drug Development

QPS Holding

Pfizer Inc.

The Emmes Company, LLC

IQVIA Inc.

View Full Report: https://www.reportsandinsights.com/report/Pediatric Clinical Trial-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: [email protected] Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

#Pediatric Clinical Trial Market share #Pediatric Clinical Trial Market size #Pediatric Clinical Trial Market trends

0 notes

stevenwilliam12 · 26 days ago

Text

Rising Demand for Cancer Cachexia Treatments: Market Insights and Forecasts Through 2032

Cancer cachexia is a complex syndrome characterized by severe weight loss, muscle wasting, and a decline in physical function, significantly impacting the quality of life for cancer patients, particularly in advanced stages. This condition complicates cancer treatment efficacy, highlighting the urgent need for effective therapeutic options, which are currently limited.

Market Overview for Cancer Cachexia

The market for cancer cachexia is poised for significant growth by 2032, driven by the global rise in cancer incidence and the increasing recognition of cachexia as a serious medical condition. As cancer rates continue to rise, so does the prevalence of cancer cachexia, creating a critical area of unmet medical need within oncology.

Key Players in the Cancer Cachexia Market

Several companies are actively engaged in developing therapies for cancer cachexia, including:

AEterna Zentaris

Aphios Corporation

Artelo BIOSCIENCES

Caelus Health

Cannabics Pharmaceuticals

Helsinn Therapeutics

Ildong Pharmaceutical

Incyte Corporation

Janssen Pharmaceutical

NGM Biopharmaceuticals

Ono Pharmaceutical

PsiOxus Therapeutics

Smartfish AS

Tetra Biopharma

Epidemiology of Cancer Cachexia

Cancer cachexia is notably prevalent among patients with advanced-stage cancers, such as pancreatic, lung, and gastrointestinal cancers. According to DelveInsight's analysis, approximately 30-50% of cancer patients experience some degree of cachexia, with the highest rates observed in patients with aggressive malignancies. In the 7MM (United States, EU4, and Japan), over 1.5 million diagnosed prevalent cases of cancer cachexia were estimated in 2023. The incidence of this condition is expected to rise over the next decade due to factors such as aging populations and increasing cancer prevalence.

Competitive Landscape

Despite the competitive nature of the cancer cachexia market, it remains underdeveloped regarding available treatments. Leading pharmaceutical companies are exploring various therapeutic strategies, including appetite stimulants, anti-inflammatory drugs, and anabolic agents. Although advancements in research are being made, no universally effective treatment for all patients has been established. Several therapies are in the pipeline, focusing on novel combinations of medications that aim to alleviate both the symptoms and underlying causes of cancer cachexia.

Market Forecast

The cancer cachexia market is projected to expand rapidly by 2032. A growing understanding of the syndrome's impact on cancer progression and patient outcomes is anticipated to drive market growth. Additionally, regulatory authorities are increasingly fast-tracking the approval of promising treatments, which will facilitate the entry of more drug candidates into clinical trials, significantly enhancing the market's size and scope.

Conclusion

In conclusion, the cancer cachexia treatment market remains a vital area for therapeutic intervention, with substantial growth potential expected in the coming decade. The need for effective treatments and the ongoing research efforts in this field underscore its importance in improving the quality of life for cancer patients.

Latest Reports Offered By DeveInsight:

0 notes

industrynewsupdates · 1 month ago

Text

Clinical Trials Market Share, Growth Analysis Top Leading Players 2024 - 2030

The global clinical trials market size is expected to reach USD 123.5 billion by 2030, expanding at a CAGR of 6.49% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed a decline of 6% in 2020 owing to the COVID-19 pandemic. However, the market is projected to recover from 2021 onwards. In addition, clinical trials have become increasingly costly, adding to the overall cost of developing a drug.

The increasing need for developing new drugs for chronic diseases, such as cancer, respiratory disorders, diabetes, cardiovascular diseases, and others, is creating immense pressure on the healthcare industry. The COVID-19 pandemic and the increasing demand for developing a suitable treatment are driving the market. The high number of people affected by the disease further depicts an increasing need for therapeutics & vaccines. Currently, there are 288 therapeutics and 106 vaccines under development, out of which, nearly 7.0% of therapeutics are in Phase IV, 21.0% in Phase III, and 43.0% & 13.0% in Phase II & Phase I, respectively.

Gather more insights about the market drivers, restrains and growth of the Clinical Trials Market

Detailed Segmentation:

Market Concentration & Characteristics

The industry growth stage is moderate, and the pace of the growth is accelerating. The clinical trials market is characterized by a moderate-to-high degree of growth owing to increasing investment in R&D programs, growing preference for outsourcing activities to minimize time, curtail clinical trial cost and patent expiration of blockbuster drugs. With increasing clinical trial privatization, there is a surge in outsourcing to developing countries, and many CROs are enhancing their global research network to provide better customer services.

Phase Insights

Phase III segment led the market and accounted for 53.3% of the total revenue share in 2023. clinical trial statistics indicate market growth due to rising phase III trials, involving a large number of subjects. The median cost for a single-phase III trial is over USD 19.0 million. Also, phase III requires a higher number of patients and often a longer treatment period. According to a clinical trial logistics survey by Nice Insights, 35.0% of phase III clinical trials are outsourced and the number is likely to increase owing to the growing number of investigational drugs advancing to the next phase.

Study Design Insights

The interventional studies segment dominated the market in 2023. It is one of the most prominent methods used in clinical trials. Interventional studies comprised over 75.0% of the total registered studies in 2022,ut of which most were for drug or biologics, followed by clinical procedure, behavioral, and device interventional studies. These studies contribute to 94.0% of the total studies that posted results, out of which drug or biologics contribute the most, followed by behavioral, devices, and Clinical procedure intervention studies.

Indication by Study Design Insights

The interventional trials market for autoimmune/inflammation accounted for the largest revenue share in 2023. This can be attributed to large number of interventional studies on autoimmune/inflammation worldwide. Numerous advantages of interventional studies, such as minimization of confounding effects, avoidance of bias in allocation to exposure groups, and efficient detection of small to moderate clinically important effects. There are over 8,900 interventional studies listed on Clinicaltrails.gov related to autoimmune/inflammation.

Indication Insights

Oncology segment accounted for the largest revenue share in 2023. As per the U.S. FDA and various other sources, more than USD 38.0 billion is currently being spent by the pharmaceutical industry on the pre-clinical and clinical development of oncology therapy products. The cardiovascular condition segment is also anticipated to witness lucrative growth over the forecast period. The growing prevalence and increased demand for cost-effective medications worldwide have led to significant investment in R&D in this segment with more than 190 drugs in the pipeline. The majority of the drugs in the pipeline are indicated for heart failure, lipid disorders, vascular diseases, and stroke. Growing demand for cost-effective medicines in low- and middle-income countries is expected to boost the R&D investment by the government, thereby strengthening the industry growth.

Sponsors Insights

Pharmaceutical & biopharmaceutical companies accounted for the largest revenue share in 2023. This can be attributed to the greater interest of the pharmaceutical industry in the research field. In addition, there has been an increase in the number of clinical trials funded by pharmaceutical & biopharmaceutical companies. The pharmaceutical industry plays a vital role in financing the research for the development of new drugs.

Regional Insights

North America accounted for 50.3% of the global market in 2023 and is expected to continue its dominance over the forecast period. This can be attributed to an increase in R&D investments and a rise in the adoption of new technologies in clinical trials in this region. For instance, the implementation of virtual services in various stages of clinical trials by market players, such as IQVIA and PRA Health Sciences, is anticipated to further propel the North American market growth.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global healthcare predictive analytics market size was estimated at USD 14.58 billion in 2023 and is projected to grow at a CAGR of 24.0% from 2024 to 2030.

• The global medical animation market size was valued at USD 396.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 20.1% from 2024 to 2030.

Key Companies & Market Share Insights

The global clinical trials market is highly competitive. Some of the players operating in the market include IQVIA, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, and Charles River Laboratory. The major factor influencing the competitive nature is the quick adoption of advanced technology for improved healthcare. In addition, to retain their market share and expand their product portfolio, major players are often involved in mergers and acquisitions as well as initiating new product launches.

Key Clinical Trials Companies:

• Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)

• ICON plc

• Charles River Laboratories International, Inc.

• IQVIA

• SYNEOS HEALTH

• SGS SA

• PAREXEL International Corporation

• Wuxi AppTec, Inc

• Chiltern International Ltd (Laboratory Corporation of America)

• Eli Lilly and Company

• Novo Nordisk A/S

• Pfizer

• Clinipace (Caidya)

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, sponsor, indication by study design, and region:

Clinical Trials Phase Outlook (Revenue, USD Billion, 2018 - 2030)

• Phase I

• Phase II

• Phase III

• Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

• Interventional

• Observational

• Expanded Access

Clinical Trials Indication by Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

• Autoimmune/Inflammation

o Rheumatoid Arthritis

o Multiple Sclerosis

o Osteoarthritis

o Irritable Bowel Syndrome (IBS)

o Others

• Pain Management

o Chronic Pain

o Acute Pain

• Oncology

o Blood Cancer

o Solid Tumors

o Other

• CNS Condition

o Epilepsy

o Parkinson's Disease (PD)

o Huntington's Disease

o Stroke

o Traumatic Brain Injury (TBI)

o Amyotrophic Lateral Sclerosis (ALS)

o Muscle Regeneration

o Others

• Diabetes

• Obesity

• Cardiovascular

• Others

Clinical Trials Indication Outlook (Revenue, USD Billion, 2018 - 2030)

• Autoimmune/Inflammation

o Interventional

o Observational

o Expanded Access

• Pain Management

o Interventional

o Observational

o Expanded Access

• Oncology

o Interventional

o Observational

o Expanded Access

• CNS Condition

o Interventional

o Observational

o Expanded Access

• Diabetes

o Interventional

o Observational

o Expanded Access

• Obesity

o Interventional

o Observational

o Expanded Access

• Cardiovascular

o Interventional

o Observational

o Expanded Access

• Others

o Interventional

o Observational

o Expanded Access

Clinical Trials Sponsor Outlook (Revenue, USD Billion, 2018 - 2030)

• Pharmaceutical & Biopharmaceutical Companies

• Medical Device Companies

• Others

Clinical Trials Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Protocol Designing

• Site Identification

• Patient Recruitment

• Laboratory Services

• Bioanalytical Testing Services

• Clinical Trial Data Management Services

• Others

Clinical Trials Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Spain

o Italy

• Asia Pacific

o India

o Japan

o China

o Australia

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

o Colombia

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

Order a free sample PDF of the Clinical Trials Market Intelligence Study, published by Grand View Research.

Recent Developments

• In August 2023, Parexel & Partex entered a strategic partnership aimed at utilizing Artificial Intelligence (AI)-driven solutions to expedite the process of drug discovery and development for biopharmaceutical clients globally. The collaboration aimed to reduce risks associated with the assets in their respective portfolios.

• In August 2023, Novo Nordisk announced to acquire Inversago Pharma. This acquisition was part of Novo Nordisk's strategic efforts to develop new therapies targeting individuals with obesity, diabetes, and other significant metabolic diseases

• In April 2022, Charles River Laboratories International, Inc. disclosed its acquisition of Explora BioLabs Holdings, Inc., a leading provider of contract vivarium research services.

#Clinical Trials Market #Clinical Trials Market size #Clinical Trials Market share #Clinical Trials Market analysis #Clinical Trials Industry

0 notes

trendingreportz · 2 months ago

Text

Medical Robotics Market - Forecast(2024 - 2030)

Medical Robotics Market Overview

Medical Robotics Market was estimated at $7.34Bn in 2019, growing at a CAGR of 7.33% during the forecast period 2020–2025. It is a technology used in healthcare industry to aid healthcare professionals diagnose and treat diseases that corrects, restores or modifies bodily functions. It allows surgeons to carry out operations more precisely and in a less invasive way. It increases the accurateness of the operation with wide range of advantages such as decreased risk of infection, decreased post-operative pain and possess less life risks. It is used to perform repetitive tasks at high speeds, reliably with the help of telemanipulators without fatigue. Rehabilitation robots, Biorobots, Telepresence robots and others are the types of robots used to perform surgeries such as kidney transplant, gallbladder removal, hysterectomy and others. Non-invasive Radiosurgery Robots is used for the treatment of oncology by medical robotic system.

Key Takeaways

Rising technological advancements to cure patients through non-invasive methods are set to promote the scope of medical robotics market size.

Rising government initiatives with an objective of improving awareness about diagnosis and treatment; increasing instances of intricate medical conditions such as cancer, cardiovascular disease, gynecological diseases and others; increasing need of automation and advanced devices is estimated to contribute to the growth of the market.

Asia-Pacific region is estimated to record the fastest growth rate during the forecast period 2020–2025.

Request Sample

By Type — Segment Analysis

In 2019, Surgical Robots segment dominated the Medical Robotics Market in terms of revenue is estimated to grow with a CAGR of 6.44%. It is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consist of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely. It is used in laparoscopic surgery with less blood loss, lesser pain and faster recovery. With better visualization it is able to operate more accurately to cure patients which are the key factor of the market’s growth.

Inquiry Before Buying

Geography — Segment Analysis

In 2019, the North America region dominated Medical Robotics Market in terms of revenue with a market share of 47%. It is owing to the relatively large federal grants from the government of health sector, government funding. The American Cancer Society introduced a nationwide program to increase the awareness about the benefits of medical robotics that is leading the market growth. Asia-Pacific region is estimated to record the fastest growth rate during the forecast period 2020–2025, owing to the presence of a large target population in China and India.

Drivers — Medical Robotics Market

Preference Of Non-Invasive Procedure

Medical robotic system uses non-invasive surgeries in the field of gynecology, cosmetology, open surgery, laparoscopic procedures, and others. These procedures offers negligible complications, diminish the threat of infections, reduce pain, and have quicker recovery. Traumatic injuries, cancers and cardiovascular disease raise the impact of surgical intervention in medical robotic market.

Schedule a Call

Challenges — Medical Robotics Market

High-Cost

It is quite evident that there is very less amount of hospitals that are capable of investing in the advanced instruments for the treatment of patients. Most of the hospital or clinical chains step back from having medical robotics owing to its high price. In the other hand, hospitals with these medical robots are forced to provide services at higher prices owing to the functional cost of the technology.

Medical Robotics Industry Outlook

Product Launches was the key strategy of the players in the Medical Robotics Industry. Medical Robotics top 10 companies include Intuitive Surgical Inc., Accuray Inc., Stryker Corporation, Hacoma AG. Major Robotics Ltd, Titan Medical Inc., Hansen Medical Inc., MedtEch S.A., Kuka Roboter GMBH, and Irobot Corporation.

Buy Now

Acquisitions/Product Launches

In February 2020, Intuitive Surgical Inc. acquired Orpheus Medical. This acquisition helped the company in enhancing its product portfolio, in offering information technology connectivity and archiving surgical video to hospitals around the world..

In July 2016, Stryker Corporation launched EMP tool that claims data and identify cost improvement and efficiency areas in order to improve outcomes and profitability in the orthopedics business.

#Medical robots #surgical robots #minimally invasive surgery #exoskeleton #robotic catheters #telemedicine robots #hospital robots #rehabilitation robots #biorobots #oncology

0 notes

market-insider · 3 months ago

Text

Veterinary Clinical Trials Market Future Outlook: Analyzing Size, Share, and Growth Patterns

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Veterinary Clinical Trials Market Report Highlights

Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.

By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.

In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.

Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.

Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.

In 2023, North America held the highest share of 33.70% of the market by region.The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

For More Details or Sample Copy please visit link @: Veterinary Clinical Trials Market Report

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

List of Key Players in the Veterinary Clinical Trials Market

Charles River Laboratory

IDEXX Laboratories, Inc.

Boehringer Ingelheim International GmbH.

Argenta

Bioagile Therapeutics Pvt. Ltd.

Veterinary Research Management

Merck & Co., Inc.

Labcorp Drug Development

OCR - Oncovet Clinical Research

Vivesto AB

Vetbiolix

#VeterinaryClinicalTrialsMarket #VeterinaryCRO #VeterinaryClinicalStudies #VeterinaryClinicalInvestigation #ClinicalTrials #VeterinaryCenter #VeterinaryMedicine #AnimalHealth #Biomarkers #VeterinaryCare #VeterinaryClinics

0 notes

jackmasonincandco · 3 months ago

Text

Jack Mason Inc & Co - Importance of AI in Healthcare Business

Artificial Intelligence (AI) is becoming increasingly crucial in the healthcare business, revolutionizing various aspects of the industry and driving significant improvements in patient care, operational efficiency, and medical research.

Here are some key areas shared by Jack Mason Inc & Co where AI is making a substantial impact:

1. Enhanced Diagnostics and Treatment AI algorithms, particularly in machine learning, are improving diagnostic accuracy by analyzing vast amounts of medical data, including imaging, lab results, and patient history. AI systems can detect patterns and anomalies that may be missed by human eyes, leading to earlier and more accurate diagnoses. This is particularly impactful in fields like radiology, oncology, and pathology, where AI aids in identifying diseases such as cancer at earlier stages.

2. Personalized Medicine

AI enables the creation of personalized treatment plans tailored to individual patients. By analyzing genetic information, lifestyle factors, and other personal data, AI can help doctors determine the most effective treatments with minimal side effects. This personalized approach enhances patient outcomes and reduces the trial-and-error nature of traditional treatment methods.

3. Operational Efficiency

AI helps streamline healthcare operations by optimizing administrative tasks, managing patient flow, and predicting resource needs. For instance, AI can automate scheduling, reduce wait times, and optimize the use of medical facilities. This not only improves patient experience but also reduces costs for healthcare providers.

4. Drug Discovery and Development

AI accelerates the drug discovery process by analyzing large datasets to identify potential drug candidates and predict their success rates. This reduces the time and cost involved in bringing new drugs to market. AI can also help in repurposing existing drugs for new treatments, opening up new avenues for therapeutic applications.

5. Remote Monitoring and Telemedicine

AI-powered tools enable continuous monitoring of patients, especially those with chronic conditions. Wearable devices and AI algorithms can track vital signs and detect early warning signs of potential health issues, allowing for timely interventions. Additionally, AI enhances telemedicine platforms by providing decision support to clinicians and ensuring that remote consultations are as effective as in-person visits.

6. Predictive Analytics

AI-driven predictive analytics can forecast disease outbreaks, patient admission rates, and other critical healthcare trends. This information helps healthcare providers prepare for future challenges, allocate resources more effectively, and make data-driven decisions to improve overall healthcare delivery.

7. Ethical and Regulatory Considerations

While AI offers numerous benefits, it also raises ethical and regulatory challenges, particularly in areas like patient privacy, data security, and bias in AI algorithms. The healthcare industry must navigate these issues carefully to ensure that AI is used responsibly and equitably.

Conclusion

AI is transforming the healthcare business by improving patient outcomes, enhancing operational efficiency, and accelerating medical research. As AI continues to evolve, its integration into healthcare will likely lead to even more significant advancements, making it an indispensable tool in the pursuit of better health for all.

Follow Jack Mason Inc & Co for more such posts!

#Jack Mason Inc & Co

0 notes

diptinaik · 3 months ago

Text

0 notes

insightfulblogz · 5 days ago

Text

Microcatheters Market Trends, Growth, Top Companies, Revenue, and Forecast to 2032

Microcatheters are advanced medical devices designed for navigating small and complex vascular systems, particularly in minimally invasive procedures. These slender catheters, usually less than 3 French in diameter, offer high precision and control, making them essential in fields such as interventional cardiology, neurology, and oncology. By enabling targeted drug delivery and assisting in complex surgical navigation, microcatheters play a critical role in enhancing patient outcomes and reducing procedural complications. Their flexibility and maneuverability make them ideal for accessing difficult-to-reach areas within the body with minimal disruption to surrounding tissues.

The Microcatheters Market Size was valued at USD 1.98 billion in 2022, and is expected to reach USD 2.71 billion by 2030 and grow at a CAGR of 4% over the forecast period 2023-2030.

Future Scope

The future of microcatheters is promising, with ongoing advancements focusing on improved materials, flexibility, and biocompatibility. Innovations such as steerable microcatheters and drug-coated options are expected to enhance procedural precision and therapeutic efficacy. As demand grows for minimally invasive interventions, the development of smaller, more versatile microcatheters that can perform multiple functions will drive growth. These devices are likely to become increasingly specialized for various procedures, particularly as interventional radiology and endovascular treatments continue to evolve.

Trends

Recent trends in microcatheter development include the incorporation of hydrophilic coatings for enhanced maneuverability and the use of high-strength yet flexible materials, such as nitinol and polymer composites. The trend toward single-use, disposable microcatheters is also rising, driven by the need for enhanced sterility and reduced infection risk. Furthermore, integration with imaging systems and robotic guidance is becoming more common, providing real-time navigation that improves procedural accuracy and outcomes.

Applications

Microcatheters are used in diverse applications, including coronary interventions, neurovascular procedures like aneurysm coiling, and cancer therapies that require localized drug delivery. They are also employed in peripheral vascular interventions, embolization, and tissue sampling. Due to their ability to navigate small and delicate vessels, microcatheters are critical in procedures that require precision, such as tumor embolization and complex cardiovascular interventions.

Key Points

Microcatheters provide high precision in minimally invasive procedures across various specialties.

Future advancements focus on improved materials, flexibility, and specialized functionality.

Trends include hydrophilic coatings, high-strength materials, and single-use designs.

Widely applied in cardiology, neurology, oncology, and vascular interventions.

Integration with imaging and robotic systems is enhancing procedural accuracy and outcomes.

Conclusion

Microcatheters are redefining the standards of minimally invasive medicine, allowing for greater precision, safety, and efficacy in a range of complex procedures. As technology advances, these devices will continue to play an essential role in expanding the possibilities of interventional medicine. The evolution of microcatheters is expected to contribute significantly to improved patient care, providing a critical tool for clinicians to perform intricate interventions with higher accuracy and patient safety.

#Microcatheters Market #Microcatheters Market Size #Microcatheters Market Share #Microcatheters Market Growth #Microcatheters Market Report

0 notes

credenceresearchdotblog · 3 months ago

Text

Fluorescence Guided Surgery (FGS) systems are revolutionizing surgical procedures by enhancing visualization, precision, and outcomes. These advanced technologies utilize fluorescence imaging to provide real-time insights into tissue and molecular environments during surgery, thereby improving the accuracy of tumor removal, reducing surgical complications, and optimizing patient recovery. The Fluorescence Guided Surgery System Market has seen significant growth in recent years due to technological advancements, increasing prevalence of cancer, and the rising demand for minimally invasive surgical techniques.

Browse the full report at https://www.credenceresearch.com/report/fluorescence-guided-surgery-system-market

Market Overview

The global Fluorescence Guided Surgery System Market was valued at approximately $1.2 billion in 2023 and is projected to grow at a robust compound annual growth rate (CAGR) of around 15% through 2030. This growth is driven by the continuous innovation in fluorescence imaging technologies, the rising incidence of cancer, and the increasing adoption of FGS systems in various surgical procedures.

Key Drivers

1. Technological Advancements: Innovations in fluorescence imaging technologies, such as the development of new fluorescent dyes and imaging devices, have significantly contributed to the growth of the FGS market. Advanced systems now offer higher resolution images, better tissue contrast, and enhanced detection capabilities, leading to more precise surgeries.

2. Rising Cancer Incidence: The increasing prevalence of cancer globally has led to a greater demand for effective surgical interventions. FGS systems are particularly useful in oncology for identifying and removing cancerous tissues more accurately, which helps in improving patient outcomes and survival rates.

3. Minimally Invasive Surgery: There is a growing preference for minimally invasive surgical procedures due to their benefits, such as reduced postoperative pain, shorter recovery times, and minimal scarring. FGS systems align well with these trends by providing detailed visualization during minimally invasive surgeries.

4. Growing Awareness and Adoption: Increased awareness among surgeons and healthcare professionals about the benefits of FGS systems is driving their adoption. Training programs and educational initiatives are helping to familiarize practitioners with the technology, further boosting market growth.

Market Segmentation

1. By Type: - Fluorescent Imaging Systems: These include devices that use fluorescent dyes or agents to visualize tissues in real-time. They are essential for providing high-definition images during surgery. - Fluorescent Dyes and Agents: These are substances used in conjunction with imaging systems to highlight specific tissues or abnormalities. Examples include indocyanine green (ICG) and 5-aminolevulinic acid (5-ALA).

2. By Application: - Oncology: FGS systems are extensively used in cancer surgeries to delineate tumors from surrounding healthy tissues, reducing the likelihood of residual disease. - Neurosurgery: These systems assist in identifying critical structures within the brain and spinal cord, improving the precision of neurosurgical procedures. - Cardiovascular Surgery: FGS technology helps in visualizing blood vessels and assessing grafts, enhancing outcomes in cardiovascular surgeries.

3. By End-User: - Hospitals: Major healthcare institutions are the primary adopters of FGS systems due to their capacity to invest in advanced technologies and their high volume of surgical procedures. - Ambulatory Surgical Centers: These centers are increasingly incorporating FGS systems to offer advanced surgical options in outpatient settings. - Research and Academic Institutions: These entities use FGS systems for experimental procedures and training purposes.

Regional Analysis

North America holds the largest share of the FGS market, driven by advanced healthcare infrastructure, high adoption rates, and significant research and development activities. Europe follows closely with a growing emphasis on cancer research and the adoption of minimally invasive surgical techniques. The Asia-Pacific region is expected to witness the highest growth rate, fueled by increasing healthcare investments, rising awareness, and the expanding patient population.

Challenges and Opportunities

Despite the promising growth, the FGS market faces challenges such as high costs of advanced imaging systems and a lack of standardized protocols for fluorescence-guided procedures. However, these challenges present opportunities for market players to innovate and develop cost-effective solutions, expand their product offerings, and enhance training and support services.

Key Player Analysis

OnLume Inc.

Karl Storz SE & Co. KG

Stryker Corporation

Medtronic PLC

Irillic Pvt. Ltd

Olympus Corporation

Getinge AB

Hamamatsu Photonics K.K.

Shimadzu Corporation

Curadel LLC

PerkinElmer, Inc.

Segments:

Based on Type:

SPY System

PDE System

VS3 Iridium System

Others

Based on Surgery:

Open Surgery

Laparoscopy/Endoscopy

Based on Application:

Cancer Surgeries

Cardiovascular Surgeries

Others

Based on the Geography:

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Australia

Rest of Asia Pacific

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

UAE

Saudi Arabia

Qatar

South Africa

Rest of the Middle East & Africa

Browse the full report at https://www.credenceresearch.com/report/fluorescence-guided-surgery-system-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

health-views-updates · 2 months ago

Text

The Future of the Intraoperative Imaging Market: Key Trends and Insights

The global intraoperative imaging market is poised for steady growth over the next decade, with its market value expected to rise from USD 2.9 billion in 2023 to USD 4.85 billion by 2032. This growth corresponds to a compound annual growth rate (CAGR) of 5.9% from 2024 to 2032. The increasing adoption of advanced imaging technologies during surgeries to improve accuracy and patient outcomes is a key driver of this market expansion.

Intraoperative imaging refers to the use of imaging modalities such as intraoperative MRI, CT, and ultrasound during surgical procedures to assist surgeons in real-time visualization, enhancing precision and ensuring the complete removal of tumors or other targeted tissues. These imaging systems enable better decision-making during complex surgeries and help reduce the likelihood of repeat procedures.

Get Free Sample PDF: https://www.snsinsider.com/sample-request/4506

Key Market Drivers

Rising Demand for Minimally Invasive Surgeries: One of the most significant factors driving the growth of the intraoperative imaging market is the increasing demand for minimally invasive surgeries (MIS). These procedures, known for smaller incisions and faster recovery times, require high precision. Intraoperative imaging systems assist surgeons in navigating complex anatomical structures, allowing for more accurate tumor resections or repairs without damaging surrounding tissues.

Technological Advancements in Imaging: Rapid technological advancements in imaging systems are further propelling the market. Innovations such as portable intraoperative imaging devices, 3D imaging, and integration with robotic surgical systems are transforming the landscape of modern surgery. These advancements are not only improving the accuracy of surgical interventions but also expanding the application areas for intraoperative imaging, making it a vital tool in neurosurgery, orthopedics, cardiovascular surgery, and oncology.

Increasing Prevalence of Chronic Diseases: The rising global incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders is another key factor fueling the demand for intraoperative imaging. As the number of surgeries to treat these conditions increases, so does the need for real-time imaging to ensure precision in treatment. In particular, intraoperative imaging is becoming indispensable in neurosurgery and oncology, where real-time visualization significantly improves patient outcomes by ensuring complete removal of tumors.

Improving Healthcare Infrastructure and Accessibility: In developing regions, improving healthcare infrastructure is contributing to the adoption of advanced surgical technologies, including intraoperative imaging systems. Government initiatives and increased healthcare spending are enabling hospitals and medical centers in emerging markets to invest in these technologies, further boosting market growth.

Challenges and Opportunities

While the intraoperative imaging market shows promising growth, certain challenges could hinder its expansion. The high cost of imaging equipment, coupled with the need for specialized training for surgeons and staff, may limit adoption, particularly in smaller hospitals and clinics. Moreover, healthcare providers must also consider factors such as the availability of skilled professionals and the integration of imaging systems with existing surgical workflows.

However, the increasing emphasis on improving patient outcomes and reducing healthcare costs through more efficient surgeries is expected to create new opportunities for the market. The development of more affordable and portable intraoperative imaging devices is likely to expand accessibility to a wider range of healthcare facilities, particularly in emerging markets.

Regional Insights

North America currently dominates the intraoperative imaging market, driven by the region's advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and significant investment in research and development. Europe follows closely, with a strong focus on improving surgical precision and patient care.

The Asia-Pacific region is expected to experience the highest growth during the forecast period, owing to rising healthcare expenditures, increasing prevalence of chronic diseases, and growing demand for advanced medical technologies. Countries such as China, India, and Japan are investing heavily in modernizing their healthcare systems, creating substantial growth opportunities for the intraoperative imaging market.

Future Outlook

The future of the intraoperative imaging market is promising, with steady growth anticipated over the next decade. As surgical procedures become more reliant on real-time imaging for precision, the demand for advanced intraoperative imaging systems is expected to rise. With a projected CAGR of 5.9% from 2024 to 2032, the market will continue to see innovations aimed at improving surgical outcomes and reducing the need for repeat procedures.

In conclusion, the intraoperative imaging market is set to grow from USD 2.9 billion in 2023 to USD 4.85 billion by 2032. The increasing demand for minimally invasive surgeries, technological advancements, and the rising prevalence of chronic diseases will be key drivers of this growth, transforming the way surgeries are performed and improving patient outcomes across the globe.

Other Trending Reports

Pancreatic Cancer Treatment Market

gRNA Market

Patient Portal Market

Continuous Glucose Monitoring Market

0 notes

tritonmarketresearchamey · 4 months ago

Text

Companion Diagnostics Market: What’s New?

With rising health consciousness and expenditure, precision medicine has emerged as a major solution to treating chronic conditions. Estimates indicate that the personalized medicine segment is expected to account for around 40% by the end of 2022, with oncology being a major therapeutic area. As a result, this growth is expected to support the expansion of the companion diagnostics market as CDx tests identify the right drug for a specific patient pool.

Triton Market Research’s report infers that the global companion diagnostics market is expected to progress at a CAGR of 12.84% during the forecast period 2022-2028.

Presently, medical treatments are typically designed using uniform patterns, with patients with the same disease undergoing matching treatments. This trial-and-error style often becomes time-consuming and ineffective. Hence, the development of precision medicine with the help of CDx widens the studied market’s scope.

CDx Development: Technological Advancements Backs Regional Growth

In addition to a growing focus on precision medicine, the expansion of the companion diagnostics market is also fueled by technological advancements. Top trends that support the market’s growth globally, especially in the Asia-Pacific, include:

Predictive Biomarkers have proven vital in calculating responses to certain therapeutic interventions. For instance, the Oncotype Dx and MammaPrint tests and KRAS employ predictive biomarkers, providing the most effective treatment to breast and colorectal cancer patients. Estimates suggest that the oncology category secures the majority of shares in the market in terms of indication. As a result, biomarkers have gained significant prominence among oncologists across nations, including India. For instance, Tata Memorial Hospital, NIMHANS, and AIIMS are striving to identify new genes and biomarkers, ultimately generating opportunities for the Asia-Pacific companion diagnostics market.

Polymerase Chain Reaction (PCR) leads the mechanism segment in terms of revenue share in 2022. It is projected to evolve at a CAGR of 13.13% during the forecasted period. Factors such as cost-efficient, faster turnaround time, and ease of application have supported its dominance in neurology and oncology applications. Besides this, PCR-based CDx has witnessed substantial growth due to approvals such as BRACAnalysis CDx by Myriad Genetics. Such developments are expected to influence market players to expand their PCR capabilities, augmenting the companion diagnostics market’s development.

Next Generation Sequencing is another major technology fueling the CDx market development. Since NGS permits rapid sequencing, it has supported major advances in determining the molecular basis of various chronic conditions. NGS is expected to become the fastest-growing segment in the mechanism category. In this regard, PCR techniques are expected to support the success of NGS technology in the upcoming years. To illustrate, NGS diagnosis and PCR techniques offer high-precision care with less turnaround time. The rising competency in genome sequencing has also generated substantial opportunities for vendors like Shuwen Biotech and Simcere Diagnostics in the Chinese companion diagnostics market.

Competitive Landscape: Strategic Highlights & Latest CDx Approvals

The inclusion of analytics and big data has helped identify various biomarker-based illness indications regularly. This has triggered businesses to enter the market through innovations. Moreover, since it’s easy to shift from one product to another, the competition among existing players has elevated over the years. Such developments have thus led to the advent of new strategies to launch and gain approvals for their CDx devices.

In August 2022, Roche Diagnostics gained approval from FDA for VENTANA MMR RxDx Panel, the first immunohistochemistry CDx test. Based on cancer biomarkers, it helps detect solid tumor patients.

Foundation Medicine’s FoundationOne CDx and Liquid CDx were authorized with various companion diagnostics claims by the FDA in June 2022.

In May 2022, BioMerieux announced approval from FDA for its BIOFIRE Joint Infection Panel. The panel tests for 31 pathogens implicated in acute joint infections and contains 8 AMR genes to optimize therapy.

Evotec SE and BioMeriux, in July 2022, declared their partnership to create the next generation of antimicrobial and actionable diagnostics to prevent antimicrobial resistance.

In July 2021, Illumina expanded its oncology partnerships with Bristol Myer Squibb, Kura Oncology, Myriad Genetics, and Merck. This joint venture aims to develop tools for precision oncology.

Growth Prospects: CDx for Targeted Cancer Medication

Earlier, the commercial success of Herceptin and Gleevec revolutionized companion diagnostics globally. However, the increased prevalence of cancer cases has led to a dramatic shift in the drug development process, from uniform to precision medicine approach, increasing the need for new CDx solutions. Hence, the demand for predictive biomarkers for targeted cancer therapeutics is expected to take center stage, thereby creating opportunities for the companion diagnostics market.

FAQ:

Q1) What is the size of the companion diagnostics market?

The companion diagnostics market obtained $5314.48 million and is expected to gain revenue worth $12740.68 million by 2028.

Q2) What are the key end-users of the companion diagnostics market?

The key end-users include pharmaceutical and biopharmaceutical companies, reference laboratories, and others.

#COMPANION DIAGNOSTICS MARKET #Lifesciences #triton market research #market research reports

0 notes

industrynewsupdates · 1 month ago

Text

Metalworking Fluids Market In-Depth Analysis and Forecast 2024 - 2030

The global metalworking fluids market size is expected to reach USD 17.45 billion by 2030, as per the new report by Grand View Research, Inc., registering a CAGR of 4.9% in the forecast period. The demand is attributed to arise in demand for automotive and industrial machinery. Individual end-use sectors, such as machinery, metal fabrication, and transportation equipment, are driving the expansion of the market.

The market is also expected to be driven by strong development in the machinery and transportation equipment end-use industries over the projected period. Manufacturing is one of the core industries in North America and Europe. Advances in the manufacturing methods for the production of sophisticated end-use products, coupled with the increase in the exports of construction machinery and power, agricultural, and automotive equipment, have fueled the market growth.

The sector is expected to benefit from increased production of construction machines and related parts for industrial, residential, and commercial construction. The rise in public-private partnerships is expected to boost the demand for a variety of construction components that use MWFs during their production. Because of the expanding building activities in these nations, emerging economies are likely to be critical for product growth.

Gather more insights about the market drivers, restrains and growth of the Metalworking Fluids Market

Detailed Segmentation:

Market Concentration & Characteristics

Phase Insights

Study Design Insights

Indication by Study Design Insights

Indication Insights

Sponsors Insights

Regional Insights

Browse through Grand View Research's Petrochemicals Industry Research Reports.

• The global ethylene oxide market size was valued at USD 36.10 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2030.

• The global vacuum grease market size was valued at USD 139.1 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.0% over the forecast period from 2024 to 2030.

Key Companies & Market Share Insights

Key Clinical Trials Companies:

• Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)

• ICON plc

• Charles River Laboratories International, Inc.

• IQVIA

• SYNEOS HEALTH

• SGS SA

• PAREXEL International Corporation

• Wuxi AppTec, Inc

• Chiltern International Ltd (Laboratory Corporation of America)

• Eli Lilly and Company

• Novo Nordisk A/S

• Pfizer

• Clinipace (Caidya)

Metalworking Fluids Market Segmentation

Grand View Research has segmented the global metalworking fluid market report based on product, application, end-use, industrial end-use, and region:

Metalworking Fluids Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Mineral

• Synthetic

• Bio-Based

Metalworking Fluids Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Neat Cutting Oil

• Water Cutting Oil

• Corrosion Preventive Oil

• Others

Metalworking Fluids End-use Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Metal Fabrication

• Transportation Equipment

• Machinery

• Others

Metalworking Fluids Industrial End-use Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)

• Construction

• Electric & Power

• Agriculture

• Automobile

• Aerospace

• Rail

• Marine

• Telecommunications

• Health Care

Metalworking Fluids Regional Outlook (Volume, Kilotons; Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o U.K.

o Russia

o Italy

o Spain

o Turkey

o Switzerland

o Denmark

o Norway

o Belgium

o Poland

o Czech Republic

o Sweden

o Finland

• Asia Pacific

o China

o Japan

o South Korea

o India

o Singapore

o Malayasia

o Thailand

o Australia

o New Zealand

• Central & South America

o Brazil

• Middle East & Africa

Order a free sample PDF of the Metalworking Fluids Market Intelligence Study, published by Grand View Research.

Recent Developments

• In April 2022, Charles River Laboratories International, Inc. disclosed its acquisition of Explora BioLabs Holdings, Inc., a leading provider of contract vivarium research services.

#Metalworking Fluids Market #Metalworking Fluids Market size #Metalworking Fluids Market share #Metalworking Fluids Market analysis #Metalworking Fluids Industry

0 notes

wellnessweb · 5 months ago

Text

Electrosurgery Market Size Forecast: Key Insights

The Electrosurgery Market size was estimated USD 6.5 billion in 2023 and is expected to reach USD 10.75 billion by 2031 at a CAGR of 6.5% during the forecast period of 2024-2031.The electrosurgery market is rapidly expanding, driven by advancements in surgical technologies and the increasing prevalence of chronic diseases requiring surgical intervention. Electrosurgical devices, which use high-frequency electrical currents to cut tissue and coagulate blood, are becoming essential tools in modern operating rooms due to their precision, reduced blood loss, and quicker recovery times for patients. The market is witnessing significant growth, particularly in minimally invasive surgeries, which benefit from electrosurgery's ability to minimize tissue damage and enhance surgical outcomes. Innovations such as the development of more sophisticated energy sources and the integration of robotics are further propelling the market forward. Additionally, the rising demand for cosmetic surgeries and the growing healthcare infrastructure in emerging economies are contributing to the market's robust expansion. As the healthcare industry continues to evolve, the electrosurgery market is poised for sustained growth, driven by continuous technological advancements and the increasing adoption of these devices across various medical disciplines.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/3394

Market Scope & Overview

The market research report is an ideal source of information, and market studies are crucial for global businesses. In order to give a qualitative and quantitative evaluation of the development of the global economy, Electrosurgery Market research examines a wide range of nations. The market research study analyses historical information and forecasts to estimate the size of the global market. The global business overview includes tables and figures with key industry statistics, market data and analysis for organizations and consumers.

The primary and secondary methodologies, well-known research techniques, and services are all examined in the Electrosurgery Market research study. In a market study, the principal market characteristics and prospects, as well as its boundaries and key rivals, corporate profiles, and general positioning strategy for both local and international markets, are all researched.

Market Segmentation Analysis

By Product

Electrosurgical Instruments

Electrosurgical Generators

Electrosurgical Accessories

Smoke Evacuation Systems

By Surgery

General Surgery

Obstetric/Gynecological Surgery

Orthopedic Surgery

Cardiovascular Surgery

Oncological Surgery

Cosmetic Surgery

Urological Surgery

NeuroSurgery

Other Surgeries

By End User

Hospitals, Clinics, and Ablation Centers

Ambulatory Surgical Centers

Research Laboratories and Academic Institutes

COVID-19 Pandemic Impact Analysis

The research goes into great depth about how these pandemics affected various regions of the world. The COVID-19 epidemic's global spread has had a significant influence on the Electrosurgery Market in a number of ways. The report also offers advice on how market participants might continue to make money in such challenging circumstances.

Regional Outlook

The Electrosurgery Market research report explains current developments in significant regional marketplaces and the various choices service providers throughout the world have. This research report covers all of Europe, North America, Latin America, Asia Pacific, and the rest of the world. A competitive market analysis ranks the top rivals based on corporate strengths and product offerings.

Competitive Analysis

The research examines the significance of the field, in addition to its many elements and anticipated repercussions. Discussions of expert perspectives, environmental facts, and marketing strategies are included. The Electrosurgery Market research covers upstream sector differences, market segmentation, business environment, demand development, cost and pricing structure, and business climate.

Key Reasons to Purchase Electrosurgery Market Report

The market report evaluates the findings of in-depth secondary research, primary interviews with subject matter experts, and internal expert interviews.

Financial analytics, fundamental data, regional engagement, sales effectiveness, product quality, and sector contribution are all used to rank the top businesses in the market.

Conclusion

The size of the market, the successful business practices of the major organizations, and the exposure of regional firms are some of the factors taken into account by Electrosurgery Market research. For the development of market-dominating methods, these insights are crucial.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.